A detailed history of Polar Capital Holdings PLC transactions in Biogen Inc. stock. As of the latest transaction made, Polar Capital Holdings PLC holds 300,000 shares of BIIB stock, worth $68.6 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares
300,000
Previous 300,000 -0.0%
Holding current value
$68.6 Million
Previous $77.6 Million 16.67%
% of portfolio
0.4%
Previous 0.55%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$253.3 - $285.89 $6.33 Million - $7.15 Million
-25,000 Reduced 7.69%
300,000 $77.1 Million
Q2 2023

Dec 13, 2023

BUY
$275.25 - $318.06 $20.6 Million - $23.9 Million
75,000 Added 30.0%
325,000 $92.6 Million
Q2 2023

Aug 14, 2023

BUY
$275.25 - $318.06 $20.6 Million - $23.9 Million
75,000 Added 30.0%
325,000 $92.6 Million
Q1 2023

Dec 13, 2023

SELL
$256.56 - $292.34 $12.8 Million - $14.6 Million
-50,000 Reduced 16.67%
250,000 $69.5 Million
Q1 2023

May 15, 2023

BUY
$256.56 - $292.34 $25.7 Million - $29.2 Million
100,000 Added 66.67%
250,000 $69.5 Million
Q4 2022

Feb 14, 2023

SELL
$252.44 - $306.72 $25.2 Million - $30.7 Million
-100,000 Reduced 40.0%
150,000 $41.5 Million
Q3 2022

Nov 14, 2022

BUY
$194.69 - $268.46 $14.6 Million - $20.1 Million
75,000 Added 42.86%
250,000 $66.8 Million
Q2 2022

Aug 15, 2022

BUY
$187.54 - $223.02 $9.38 Million - $11.2 Million
50,000 Added 40.0%
175,000 $35.7 Million
Q1 2022

May 16, 2022

SELL
$193.77 - $244.14 $4.84 Million - $6.1 Million
-25,000 Reduced 16.67%
125,000 $26.3 Million
Q4 2021

Feb 14, 2022

BUY
$223.92 - $287.77 $5.6 Million - $7.19 Million
25,000 Added 20.0%
150,000 $36 Million
Q2 2021

Aug 16, 2021

SELL
$259.0 - $414.71 $19.4 Million - $31.1 Million
-75,000 Reduced 37.5%
125,000 $43.3 Million
Q1 2021

May 17, 2021

BUY
$242.95 - $284.63 $12.1 Million - $14.2 Million
50,000 Added 33.33%
200,000 $56 Million
Q4 2020

Feb 16, 2021

BUY
$236.26 - $355.63 $35.4 Million - $53.3 Million
150,000 New
150,000 $36.7 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $33B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Polar Capital Holdings PLC Portfolio

Follow Polar Capital Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Polar Capital Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Polar Capital Holdings PLC with notifications on news.